Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

duloxetine

Known as: N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine, N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide 
A drug used to treat depression and peripheral neuropathy (pain, numbness, tingling, burning, or weakness in the hands or feet) that can occur with… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
OBJECTIVE To develop concise, up-to-date, patient-focused, evidence-based, expert consensus guidelines for the management of knee… Expand
  • table I
  • figure 1
Review
2014
Review
2014
BACKGROUND Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 7
Highly Cited
2013
Highly Cited
2013
IMPORTANCE There are no known effective treatments for painful chemotherapy-induced peripheral neuropathy. OBJECTIVE To… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2012
Review
2012
To update the American College of Rheumatology (ACR) 2000 recommendations for hip and knee osteoarthritis (OA) and develop new… Expand
Highly Cited
2012
Highly Cited
2012
Summary Conditioned pain modulation (CPM) predicts efficacy of duloxetine in painful diabetic neuropathy; patients with less… Expand
Review
2010
Review
2010
Background and objectives:  This second European Federation of Neurological Societies Task Force aimed at updating the existing… Expand
Highly Cited
2006
Highly Cited
2006
Background: Serotonin (5-HT) and norepinephrine (NE) are involved in pain modulation via descending inhibitory pathways in the… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2005
Highly Cited
2005
&NA; The aim of this study was to examine the efficacy and safety of duloxetine, a balanced and potent dual reuptake inhibitor of… Expand
Highly Cited
2005
Highly Cited
2005
OBJECTIVE Assess efficacy and safety of duloxetine, a selective serotonin and norepinephrine reuptake inhibitor, on the reduction… Expand
Highly Cited
2004
Highly Cited
2004
OBJECTIVE To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2